Articles related to SKIN CANCER

Basal cell carcinoma, while common, rarely leads to death when detected and treated early. Physicians should be aware of the seven warning signs that can be mistaken for harmless skin conditions.

With nearly ten years of follow-up, dabrafenib plus trametinib demonstrates a sustained improvement in survival outcomes for patients with stage III BRAF V600–mutated melanoma, presenting a viable long-term strategy in melanoma management.

A phase 3 trial comparing neoadjuvant ipilimumab plus nivolumab followed by surgery to adjuvant nivolumab alone in resectable stage III melanoma patients found a significantly higher event-free survival rate in the neoadjuvant group. This suggests that pre-surgical immunotherapy could lead to better patient outcomes.

The integration of AI in skin cancer diagnostics not only improves the accuracy of diagnoses—achieving a sensitivity of 81.1% and specificity of 86.1%—but also supports the broader application of AI tools in enhancing patient care across various medical specialties.

Amtagvi’s approval introduces a novel approach in the treatment of advanced melanoma, employing patient-derived TIL-cell therapy to target tumors with precision, offering a beacon of hope for those with limited options.

Equip yourself with comprehensive knowledge about skin cancer to better educate your patients. Learn more about its types, symptoms, risk factors, diagnosis methods, treatments, stages, complications, and prevention strategies.